Turkmenistan Medical Device Registration: Manufacturer Legal Status Documents
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Turkmenistan requires documents proving that the manufacturing enterprise has completed state registration as a legal entity, and the evidence must contain six elements:
- Name of the organization;
- State registration number;
- Type of business activity;
- Legal address;
- Form of ownership;
- Information on the head of the manufacturing enterprise.
This is the most granular requirement on corporate identity in the entire dossier, and it is also the item most likely to trigger a request for supplementation when the granularity of the submitted evidence falls short. Reviewers read this document as a complete portrait of the company: every one of the six elements must be locatable in the paperwork without inference, because the reviewer has no obligation to reconstruct missing attributes from other sources. A business licence alone is frequently not enough, and the file should be assembled so that all six attributes are demonstrated on the face of the documents.
2. Legal basis
| Regulation | Reference number | Publication date | Provisions |
|---|---|---|---|
| Law of Turkmenistan on the Supply of Medicines | No. 319-V | January 12, 2016 | Documentation requirements for national registration |
| Regulation on State Registration of Medicines and Medical Devices | No public number (approved by the Ministry of Health) | Current version | Certificate of state registration of the manufacturing enterprise as a legal entity and its required elements |
3. Expert insights
Insight 1: The six elements form a corporate portrait; a business licence alone is not enough.
A business licence issued in the Chinese mainland typically states the name, unified social credit code, type, registered domicile, legal representative, and business scope. Mapped against the six required elements, the correspondence is line by line: name, registration number, form of ownership, legal address, head of the enterprise, and type of business activity. But the translation and presentation must allow the reviewer to locate each of the six elements one to one; otherwise the file will be sent back for correction. Where the licence does not state an element explicitly — for example, form of ownership — a supplementary document such as the articles of association should close the gap rather than leaving the reviewer to guess.
Insight 2: The type of business activity must prove that the enterprise actually manufactures devices.
The function of this element is to confirm that the manufacturing activity for the products under application falls within the registered business scope of the enterprise. If the business scope wording on the licence is generic, it is advisable to supplement the file with the company charter or a dedicated statement of business scope that names the manufacture of medical devices and, ideally, the relevant product families. This closes the most common objection on this document.
Insight 3: The legal address is the cross-checking baseline for several other documents.
The legal address appears simultaneously on the application form, the ISO 13485 certificate, the certificate of free sale, the instructions for use, and the label. All five documents must be verbatim identical, including punctuation and floor-level details. Any variation, however minor it seems, invites a clarification request that can otherwise be avoided with a single controlled string maintained in the dossier glossary.
Insight 4: This document normally has to go through consular legalization.
As a document evidencing legal entity status, it belongs to the same category as the power of attorney and the certificate of free sale: documents that must be submitted as originals or legalized copies. The document chain schedule in the corresponding chapter of this series must include it. Because legalization involves notarization, competent authority attestation, and consular processing, lead time should be planned in weeks rather than days, and multiple certified copies are prudent when one dossier serves several filings.
Insight 5: Contract manufacturing requires an additional agreement on reserved decision rights.
The regulatory language separately lists an agreement between the manufacturing site and the owner of the registration documentation reserving the rights over production and quality decisions, where applicable. Under a contract manufacturing (OEM/ODM) structure, this agreement is required, and it must make clear who holds responsibility for production decisions and who holds responsibility for quality decisions. The document answers a question the reviewer otherwise cannot resolve from the licence: the factory is registered as a legal entity, but the product design and quality system may belong to another party.
4. Practical recommendations
- Check the business licence against the six elements one by one and supplement missing items with the charter or a dedicated statement.
- Supplement the business scope evidence to show that device manufacturing falls within the registered scope.
- Keep the legal address verbatim identical across the five documents where it appears.
- Include this document in the consular legalization chain schedule.
- For OEM/ODM structures, prepare the agreement reserving production and quality decision rights in advance.
5. Verification checklist
- □ The business licence evidence covers the six elements (name, registration number, business activity, address, form of ownership, head of the enterprise).
- □ The business scope evidence demonstrates the device manufacturing activity.
- □ The legal address is verbatim identical across the five documents.
- □ This document has been scheduled into the consular legalization chain.
- □ The agreement on reserved decision rights is ready for OEM/ODM structures.
Regulatory information verified as of October 30, 2026. The content cited in this article was cross-checked against the Law of Turkmenistan on the Supply of Medicines No. 319-V of January 12, 2016 and the Regulation on State Registration of Medicines and Medical Devices approved by the Ministry of Health (the six elements of the certificate of state registration of the manufacturing enterprise as a legal entity); the applicability of the agreement reserving production and quality decision rights in contract manufacturing situations is handled as a practical estimate.
- GRZAN local resources in Turkmenistan: GRZAN supports manufacturers, importers, and authorized representatives by coordinating licensed local import entities and authorized representative resources, covering national registration submissions, the consular legalization chain for documents, sample delivery, liaison with mandatory TDS certification, and customs clearance support.
- Service capabilities: classification assessment, registration pathway selection, preparation of dossiers in the approved national formats, consular legalization and notarization, preparation of test and stability documentation, organization of GMP and ISO 13485 evidence, change procedures and certificate renewal, vigilance and post-market maintenance.
- Contact: info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us